未登录 分享 收藏
分享 收藏
Impact of the Standardization of Penile Cancer Care on the Quality of Care, Outcomes, and Academic-driven Centralization in a Single eUROGEN Referral Center Pecoraro, Alessio; Elst, Laura; Roussel, Eduard; Miletic, Marija; Vanthoor, Joren; De Ridder, Dirk; Van Rompuy, Anne-Sophie; De Cuyper, Eline; Dumez, Herlinde; De Meerleer, Gert; de Wever, Liesbeth; Goffin, Karolien; Van Poppel, Hendrik; Joniau, Steven; Albersen, Maarten 分享 收藏
分享 收藏
SPARKLE: a new spark in treating oligorecurrent prostate cancer: adding systemic treatment to stereotactic body radiotherapy or metastasectomy: key to long-lasting event-free survival? Rans, Kato; Charlien, Berghen; Filip, Ameye; Olivier, De Hertogh; Julie, den Hartog; Cederic, Draulans; Herlinde, Dumez; Benedikt, Engels; Karolien, Goffin; Annouschka, Laenen; Nick, Liefhooghe; Kenneth, Poels; Carl, Salembier; Koen, Slabbaert; Hans, Vandendriessche; Ben, Vanneste; Steven, Joniau; Gert, De Meerleer 分享 收藏
First-in-man, first-in-class phase I study with the monopolar spindle 1 kinase inhibitor S81694 administered intravenously in adult patients with advanced, metastatic solid tumours Schoeffski, Patrick; Awada, Ahmad; de la Bigne, Anne-Marie; Felloussi, Zakia; Burbridge, Mike; Cantero, Frederique; Colombo, Riccardo; Maruzzelli, Sara; Ammattatelli, Katia; de Jonge, Maja; Aftimos, Philippe; Dumez, Herlinde; Sleijfer, Stefan 分享 收藏
TALAPRO-1: Talazoparib (TALA) monotherapy in metastatic castration-resistant prostate cancer (mCRPC) with DNA damage response alterations (DDRm) - Exploration of non-DDR mutational landscape and potential associations with antitumor activity Mehra, N.; de Bono, J.; Laird, A. D.; Barthelemy, P.; Delva, R.; Dorff, T.; Maruzzo, M.; Stirling, A.; Machiels, J-P.; Dumez, H.; Renard, V.; Hopkins, J.; Albacker, L. A.; Chen, H-C.; Healy, C.; Chelliserry, J.; van Oort, I. M.; Scagliotti, G.; Fizazi, K. 分享 收藏
Safety and efficacy of atezolizumab in patients with autoimmune disease: Subgroup analysis of the SAUL study in locally advanced/metastatic urinary tract carcinoma Loriot, Yohann; Sternberg, Cora N.; Castellano, Daniel; Oosting, Sjoukje F.; Dumez, Herlinde; Huddart, Robert; Vianna, Karina; Gordoa, Teresa Alonso; Skoneczna, Iwona; Fay, Andre P.; Nole, Franco; Massari, Francesco; Brasiuniene, Birute; Maroto, Pablo; Fear, Simon; Di Nucci, Flavia; de Ducla, Sabine; Choy, Ernest 分享 收藏
分享 收藏
TALAPRO-1: Talazoparib (TALA) monotherapy in men with DNA damage response alterations (DDRalt) and metastatic castrationresistant prostate cancer (mCRPC): Exploration of DDRalt germline/somatic origin Mehra, N.; Fizazi, K.; Laird, A. D.; Barthelemy, P.; Delva, R.; Dorff, T.; Maruzzo, M.; Stirling, A.; Machiels, J-P.; Dumez, H.; Renard, V.; Albacker, L. A.; Hopkins, J.; Chen, H-C.; Mata, M.; Di Santo, N.; Healy, C. G.; Van Oort, I. M.; Buttigliero, C.; de Bono, J. S. 分享 收藏
Metastasis-directed therapy in castration-refractory prostate cancer (MEDCARE): a non-randomized phase 2 trial Berghen, Charlien; Joniau, Steven; Rans, Kato; Devos, Gaetan; Poels, Kenneth; Slabbaert, Koen; Dumez, Herlinde; Albersen, Maarten; Goffin, Karolien; Haustermans, Karin; De Meerleer, Gert 分享 收藏
A randomized, double-blind, placebo-controlled phase II study of maintenance therapy with tasquinimod in patients with metastatic castration-resistant prostate cancer responsive to or stabilized during first-line docetaxel chemotherapy Fizazi, K.; Ulys, A.; Sengelov, L.; Moe, M.; Ladoire, S.; Thiery-Vuillemin, A.; Flechon, A.; Guida, A.; Bellmunt, J.; Climent, M. A.; Chowdhury, S.; Dumez, H.; Matouskova, M.; Penel, N.; Liutkauskiene, S.; Stachurski, L.; Sternberg, C. N.; Baton, F.; Germann, N.; Daugaard, G. 分享 收藏
分享 收藏
A first in man, dose-finding study of the mTORC1/mTORC2 inhibitor OSI-027 in patients with advanced solid malignancies Mateo, Joaquin; Olmos, David; Dumez, Herlinde; Poondru, Srinivasu; Samberg, Nancy L.; Barr, Sharon; Van Tornout, Jan M.; Jie, Fei; Sandhu, Shahneen; Tan, Daniel S.; Moreno, Victor; LoRusso, Patricia M.; Kaye, Stan B.; Schoffski, Patrick 分享 收藏
Phase I trial of volasertib, a Polo-like kinase inhibitor, plus platinum agents in solid tumors: safety, pharmacokinetics and activity Polo样激酶抑制剂volasertib加铂类药物在实体瘤中的I期试验: 安全性，药代动力学和活性 Awada, Ahmad; Dumez, Herlinde; Aftimos, Philippe G.; Costermans, Jo; Bartholomeus, Sylvie; Forceville, Kathleen; Berghmans, Thierry; Meeus, Marie-Anne; Cescutti, Jessica; Munzert, Gerd; Pilz, Korinna; Liu, Dan; Schoeffski, Patrick 分享 收藏
Prognostic impact of baseline serum C-reactive protein in patients with metastatic renal cell carcinoma (RCC) treated with sunitinib Beuselinck, Benoit; Vano, Yann-Alexandre; Oudard, Stephane; Wolter, Pascal; De Smet, Robert; Depoorter, Lore; Teghom, Corine; Karadimou, Alexandra; Zucman-Rossi, Jessica; Debruyne, Philip R.; Van Poppel, Hendrik; Joniau, Steven; Lerut, Evelyne; Strijbos, Michiel; Dumez, Herlinde; Paridaens, Robert; Van Calster, Ben; Schoffski, Patrick 分享 收藏
Pharmacodynamics of OSI-027, a dual mTORC1/mTORC2 inhibitor, in tumor and surrogate tissues: Results from the expansion phase of a first-in-man study. Mateo, Joaquin; Schoffski, Patrick; Olmos, David; Dumez, Herlinde; Moreno, Victor; Jie, Fei; Poondru, Srinivasu; Samberg, Nancy L.; Van Tornout, Jan M.; Kaye, Stanley B.; LoRusso, Patricia M. 分享 收藏
Phase I study of two dosing schedules of BI 847325, an orally administered dual inhibitor of MEK and aurora kinase B, in patients with advanced solid tumors. Aftimos, Philippe; Dumez, Herlinde; Awada, Ahmad; Billiet, Maureen; Deleporte, Amelie; De Block, Katrien; Costermans, Jo; Meeus, Marie-Anne; Goeldner, Rainer-Georg; Schnell, David; Lee, Chooi; Schoffski, Patrick 分享 收藏
18F-MK-9470 PET imaging of the type 1 cannabinoid receptor in prostate carcinoma: a pilot study Emonds, Kimy M.; Koole, Michel; Casteels, Cindy; Van den Bergh, Laura; Bormans, Guy M.; Claus, Filip; De Wever, Liesbeth; Lerut, Evelyne; Van Poppel, Hendrik; Joniau, Steven; Dumez, Herlinde; Haustermans, Karin; Mortelmans, Luc; Goffin, Karolien; Van Laere, Koen; Deroose, Christophe M.; Mottaghy, Felix M. 分享 收藏
Phase I study of pulsatile 3-day administration of afatinib (BIBW 2992) in combination with docetaxel in advanced solid tumors Awada, A. H.; Dumez, H.; Hendlisz, A.; Wolter, P.; Besse-Hammer, T.; Uttenreuther-Fischer, M.; Stopfer, P.; Fleischer, F.; Piccart, M.; Schoffski, P. 分享 收藏
.png){kind=icon}
未登录.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
